Search results
Results from the WOW.Com Content Network
If less than 3% weight loss is seen after 3 months it is recommended the medication be stopped. [3] The weight loss is modest. [ 3 ] Effects on heart related health problems or death is unclear.
Prescription drug list prices in the United States continually are among the highest in the world. [1] [2] The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015.
In the U.S., the Emergency Medical Treatment and Active Labor Act requires that hospitals treat all patients in need of emergency medical care without considering patients' ability to pay for service. [27] This government mandated care places a cost burden on medical providers, as critically ill patients lacking financial resources must be treated.
The prices hospitals negotiate with health insurance companies are a major driver of high U.S. medical costs. WSJ analyzes the rates at one hospital to explain why the prices for the same surgery ...
Medication costs can be the selling price from the manufacturer, that price together with shipping, the wholesale price, the retail price, and the dispensed price. [3]The dispensed price or prescription cost is defined as a cost which the patient has to pay to get medicines or treatments which are written as directions on prescription by a prescribers. [4]
The operative report is dictated right after a surgical procedure and later transcribed into the patient's record. The operative report includes preoperative and postoperative diagnoses, patient condition after surgery, all medications used in association with the procedure, pertinent medical history (Hx) , physical examination (PE), consent ...
Health care cost as percent of GDP (total economy of a nation). [2] [3] Graph below is life expectancy versus healthcare spending of rich OECD countries. US average of $10,447 in 2018. [7] See: list of countries by life expectancy.
Vivus also developed an obesity drug, Qnexa (now called Qsymia), a combination of phentermine and topiramate, two existing weight-loss drugs. [4] On July 17, 2012, The U.S. Food and Drug Administration approved Qsymia ( phentermine and topiramate extended-release ), made by Vivus, as an addition to a reduced-calorie diet and exercise for ...